# Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer

> **NCT07117864** · NA · RECRUITING · sponsor: **QIAO LI** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **COMBINATION_PRODUCT:** T-DXd concurrent brain radiotherapy

## Key facts

- **NCT ID:** NCT07117864
- **Lead sponsor:** QIAO LI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07117864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07117864, "Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07117864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*